ライフサイエンスコーパス: renal vein

1 aortic aneurysm (AAA) rupture into the left renal vein.

2 on of both pre- and retro-aortic part of the renal vein.

3 aneurysm and the posterior wall of the right renal vein.

4 and distance of filter tip from the nearest renal vein.

5 ake and diverges after its appearance in the renal vein.

6 and 1 had a duplicated IVC draining the left renal vein.

7 shing (RF) of 7 living donor kidneys via the renal vein.

8 ly increased hydrostatic pressure within the renal vein.

9 ed from the right femoral vein into the left renal vein.

10 al artery, and two anomalies of the draining renal veins.

11 c isotonic fluid delivery (HIFD) to the left renal vein 24 hours after inducing moderate-to-severe un

12 s were taken from the femoral artery and the renal vein after 4 h of [6,6-2H2]glucose infusion (for g

13 ood in the infrarenal inferior vena cava and renal veins after intravenous administration of gadopent

14 risk for allograft loss as a consequence of renal vein and artery thrombosis.

15 Length of renal vein and artery were equivalent (2.4/3.4 vs. 2.3/3

16 trations of vitamin D metabolites across the renal vein and artery.

17 , its fistulous communication with the right renal vein and circumaortic renal collar in a single pat

18 with T1 measurements of flowing blood in the renal vein and in a systemic vessel 10-300 minutes after

19 Baseline renal vein and inferior vena cava levels of inflammatory

20 (VTT), where the primary tumour invades the renal vein and inferior vena cava, affects 10-15% of ren

21 Postoperatively, progressive renal vein and simultaneous iliac venous enlargement was

22 of sampling catheters in the right and left renal veins and femoral artery and an infusion catheter

23 of sampling catheters in the right and left renal veins and femoral artery and of an infusion cathet

24 ors through various routes such as systemic, renal vein, and renal arterial injections.

25 arent signs of clotting at the renal artery, renal vein, and ureter.

26 oduction of TGF-beta and endothelin, aortic, renal vein, and urinary levels of these factors were mea

27 and evaluated for IVC diameter, location of renal veins, and presence of thrombus and venous anomali

28 a circumaortic renal collar, which is a rare renal vein anomaly.

29 n 23 of 28 patients, including a single left renal vein anterior to the aorta (n = 16), retroaortic l

30 trumented with a renal artery flow probe and renal vein cannula.

31 easure total EGP) combined with arterial and renal vein catheterization and para-aminohippuric acid i

32 All study subjects had their renal vein catheterized under fluoroscopy, and net renal

33 osmolar citrate solution (3 mug/ml) with the renal vein clamped and into autologous blood (0.15 mug/m

34 CT depicted 95 of 98 renal veins confirmed at surgery.

35 d significantly higher levels from artery to renal vein, demonstrating net kidney release.

36 y 60% of all glucose carbons released in the renal vein during hypoglycemia.

37 gered technique produced 4.6 times less left renal vein enhancement than did the conventional method

38 Renal vein glycerol-3-phosphate (G-3-P) had the stronges

39 our knowledge, communication with the right renal vein has not been described in published literatur

40 The large and variable size of the renal vein has prompted most surgeons to select linear s

41 ts were created from the renal artery to the renal vein in 10 swine.

42 mples collected from the abdominal aorta and renal vein in 17 participants undergoing simultaneous ri

43 In addition, renal vein injection of adeno-associated virus 2 (AAV2)

44 re significantly associated with evidence of renal vein invasion (P = .022 and .046, respectively).

45 R angiograms depicted all seven instances of renal vein involvement, including extension to the infer

46 h its fistulous communication with the right renal vein is a rare entity.

47 d its fistulous communication with the right renal vein is a very rare entity.

48 is the preferred allograft because the right renal vein is shorter.

49 The bowel was traversed in two animals, and renal vein laceration occurred during two procedures bec

50 In addition, we measured renal vein levels of neutrophil gelatinase-associated li

51 lic blood pressure (SBP), renal hypoxia, and renal vein levels of pro-inflammatory marker tumor necro

52 isconnection of the portacaval shunt by left renal vein ligation (LRVL) is another option but require

53 th nonspecific abdominal pain, with the left renal vein (LRV) lodged between the aorta and the superi

54 ire placed in the iliac vein (n = 5) or left renal vein (n = 1).

55 c left renal vein (n = 2), circumaortic left renal vein (n = 2), and single right renal vein (n = 3).

56 rior to the aorta (n = 16), retroaortic left renal vein (n = 2), circumaortic left renal vein (n = 2)

57 ic left renal vein (n = 2), and single right renal vein (n = 3).

58 Renal vein neutrophil gelatinase-associated lipocalin, t

59 m 171 +/- 9 to 272 +/- 9 (all P < 0.05), and renal vein norepinephrine increased from 236 +/- 13 to 4

60 c technique have increased the length of the renal vein obtained from either side; however, further t

61 Simic et al. screened plasma taken from the renal vein of patients undergoing cardiac catheterizatio

62 Kidney cancer is associated with renal vein or inferior vena cava (IVC) thrombus in up to

63 l delivery of AAV-KP1, but not AAV9, via the renal vein or pelvis effectively transduces proximal tub

64 of renal sinus fat, renal collecting system, renal vein, or perinephric fat; and morphologic and phys

65 The renal vein required reconstruction more often with right

66 merular filtration rate were measured by the renal vein retrograde thermodilution technique and by re

67 exposure and further shortening of the right renal vein (RRV) after a stapled transection.

68 r a 150-min equilibration period, artery and renal vein samples were obtained between -30 and 0 min,

69 Arterial and renal vein samples were obtained in the postabsorptive s

70 Left renal vein suppression, inferior vena cava suppression,

71 ns were more prevalent in the en bloc group: renal vein thrombosis (one case), thrombosis of donor ao

72 Early reports noted a higher incidence of renal vein thrombosis and eventual graft loss.

73 Early graft loss from renal vein thrombosis occurred in two singly implanted k

74 omes of rare subgroups of pediatric VTE (eg, renal vein thrombosis), and will be important to ultimat

75 lications, including deep venous thrombosis, renal vein thrombosis, and pulmonary embolism.

76 ts with membranous nephropathy may be due to renal vein thrombosis, malignant hypertension, or an add

77 hemorrhage, retroperitoneal collaterals, and renal vein thrombosis.

78 es due to abdominal complications, all after renal vein thrombosis.

79 ing the early experience of these centers to renal vein thrombosis.

80 y in which a child had died perinatally from renal vein thrombosis.

81 ed for pT2 tumors (up to 15 cm), and level I renal vein thrombus is not a formal contraindication for

82 good flow from the splenic vein to the left renal vein through the shunt track 1 hour after creation

83 artery and vein and the hepatic, portal, and renal veins to determine total hemoglobin and oxygen con

84 tein expression between the primary tumours, renal vein tumour thrombi and metastases.

85 stases compared with the primary tumours and renal vein tumour thrombi.

86 from 177 patients with primary renal tumour, renal vein tumour thrombus and/or RCC metastasis has bee

87 lthy subjects had arterialized hand vein and renal vein (under fluoroscopy) catheterized after an ove

88 cts had arterialized hand veins (artery) and renal veins (under fluoroscopy) catheterized after an ov

89 This was utilized as the site of the renal vein venous anastomosis.

90 Distance from renal veins was noncontributory.

91 te, and sampling from the femoral artery and renal veins was performed.

92 ated incidental finding of circumaortic left renal vein with gross aneurysmal dilatation of both pre-